Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mirvat Alasnag , Julia Grapsa , Ahmed Krimly Added: 1 year ago
Join this insightful discussion on women's cardiovascular health!ICR3 Guest Editor, Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), leads a conversation with Drs Julia Grapsa (Guy's and St Thomas' NHS Foundation Trust, UK) and Ahmed Krimly (King Faisal Cardiac Center, SA), authors of a special focus issue on this critical topic.Key themes explored:Disparities in heart failure care for… View more
Author(s): Marta Cvijic Added: 1 year ago
ESC 23 — In this collaboration between Women as One and Radcliffe Cardiology, Dr Marta Cvijic (University Medical Centre Ljubljana, SI) is joined by Prof Julia Grapsa (Guy's and St Thomas' NHS Trust Hospitals, UK) to discuss the latest data on women's health from ESC 2023. In this video, they discuss the latest heart failure guidelines, the STEP-HFpEF trial, and the unmet need for more trials… View more
Author(s): Victoria Delgado , Laura Sanchis , Julia Grapsa , et al Added: 5 months ago
About the CLIMB® Skills Training ProgramNow in its fifth year,the CLIMB program hasprovided free,advanced clinical skills training to over 390women physicians from 99 countries.This online program helps address the underrepresentation ofwomenin advanced procedural cardiology subspecialties.Physicians worldwide will now have on-demand access to didactic presentations delivered by leading faculty… View more
Author(s): Rasha Al-Lamee , Roisin Colleran , Valeria Paradies Added: 1 year ago
ESC 23 — In this collaboration between Women as One and Radcliffe Cardiology, Dr Rasha Al-Lamee (Imperial College London, UK) is joined by Dr Róisín Colleran (Mater Private Hospital, Dublin, IE) and Dr Valeria Paradies (Maasstad Hospital, Rotterdam, the Netherlands, NL) to discuss the latest data on women's health from ESC 2023. In this video, Dr Al-Lamee, Dr Colleran and Dr Paradies discuss… View more
Author(s): F Aaysha Cader , Shrilla Banerjee Added: 1 year ago
AHA 2023 — Dr Fathima Aaysha Cader (Kettering General Hospital, UK) and Dr Shrilla Banerjee (Surrey & Sussex Healthcare NHS Trust, UK), winners of Women as One’s Escalator Award Mentor-Match Award, joined us to discuss their project aiming to support mentors and mentees worldwide.In this short summary, Dr Cader and Dr Banerjee share the results of a mentorship survey that included 1210… View more
Author(s): F Aaysha Cader , Shrilla Banerjee Added: 1 year ago
AHA 2023 — Dr Fathima Aaysha Cader (Kettering General Hospital, UK) and Dr. Shrilla Banerjee (Surrey & Sussex Healthcare NHS Trust, UK), winners of Women as One’s Escalator Award Mentor-Match Award, joined us to discuss their experience with developing a tool aimed to make the mentorship experience effective both for the mentee and mentor.In this short video they also talk about the work on Women… View more
Author(s): Ruth Masterson Creber Added: 3 months ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different… View more
Author(s): Diana Hui Ping Foo Added: 2 months ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,… View more
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the design and baseline characteristics of the FINE-HEART(Bayer) integrated pooled analysis of finerenone, an on-steroidal mineralocorticoid receptor (MRA) antagonist, in over 19000 patients with heart failure and CKD.FINE-HEART includes patients with type 2 diabetes, chronic kidney disease and/or… View more